Use of ICS/LABA combinations or LAMA is associated with a lower risk of acute exacerbation in patients with coexistent COPD and asthma
The Journal of Allergy and Clinical Immunology: In Practice | Feb 15, 2018
Most read this week
The Journal of Allergy and Clinical Immunology: In Practice | Feb 15, 2018